ZIOPHARM Oncology (ZIOP)

Add to Watchlists Create an Alert
1.72 -0.07  -3.91%   NASDAQ May 22, 4:59PM BATS Real time Currency in USD

ZIOPHARM Oncology Revenue Quarterly YoY Growth:

0.00% for March 31, 2013
View Full Chart

ZIOPHARM Oncology Revenue Quarterly YoY Growth Chart

    ZIOPHARM Oncology Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 0.00%
    Dec. 31, 2012 0.00%
    Sept. 30, 2012 0.00%
    June 30, 2012 0.00%
    March 31, 2012 198.5%
    Dec. 31, 2011
    Sept. 30, 2011
    June 30, 2011
    March 31, 2011
    Dec. 31, 2010
    Sept. 30, 2010
    June 30, 2010
    March 31, 2010
    Dec. 31, 2009
    Sept. 30, 2009
    June 30, 2009
    March 31, 2009
    Dec. 31, 2008
    Sept. 30, 2008
    June 30, 2008
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
       
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    ZIOP Revenue Quarterly YoY Growth Benchmarks

    Companies
    Threshold Pharmaceuticals 1060%
    United Therapeutics Corporation 20.04%
    Celsion Corporation

    ZIOP Revenue Quarterly YoY Growth Rankings

    Overall 61st percentile
    3097 of 8005
    Sector 52nd percentile
    329 of 686 in Healthcare
    Industry 68th percentile
    79 of 248 in Biotechnology

    ZIOP Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum 0.00% Jun 2012
    Maximum 198.5% Mar 2012
    Average 39.70%